Eziologia - Tumorinet

  1. Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer. 2003 Nov 3; 89(9): 1672-85.

  2. Sant M, Aareleid T, Berrino F et al. Summary of main EUROCARE-3 survival results with commentaries. Ann Oncol 2003. In press

  3. Zappa M , Falini P, Bonardi R et al. Monitoring interval cancers in mammographic screening: the Florence District programme experience. The Breast 2002; 11:301-5

  4. IARC Handbooks of Cancer Prevention, eds. Weight control and physical activity. Vol 6. Lyon: IARC Press; 2002.

  5. de Lignieres B, de Vathaire F, Fournier S, Urbinelli R, Allaert F, Le MG, Kuttenn F. Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric. 2002 Dec; 5(4): 332-40.

  6. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002 Apr 17; 94(8): 606-16.

  7. Sieri S, Krogh V, Muti P, Micheli A, Pala V, Crosignani P, Berrino F. Fat and protein intake and subsequent breast cancer risk in postmenopausal women. Nutr Cancer. 2002;42(1):10-7.

  8. Campagnoli C, Abba C, Ambroggio S, Biglia N, Ponzone R. Breast cancer and hormone replacement therapy: putting the risk into perspective. Gynecol Endocrinol. 2001 Dec; 15 Suppl 6: 53-60. Review.

  9. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001 Nov 7; 286(17): 2143-51. Review.

  10. Sant M; Eurocare Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer. 2001 Sep15;93(6):894-901.

  11. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):25-33.

  12. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000 Jan 26; 283(4): 485-91. Erratum in: JAMA 2000 Nov 22-29;284(20):2597.

  13. Muti P, Stanulla M, Micheli A, Krogh V, Freudenheim JL, Yang J, Schunemann HJ, Trevisan M, Berrino F. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes Control. 2000 Sep; 11(8): 721-30.

  14. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000 Feb 16; 92(4): 328-32.

  15. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic DW, Bradlow HL, Hankinson SE. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12): 1059-64.

  16. Berrino F.Epidemiologia analitica. In Veronesi (ed): Senologia oncologica. Masson 1999; 24-43

  17. Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W. Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998 Sep; 7(9): 783-9.

  18. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer. 1997; 75(7): 1075-9.

  19. Larsson LG, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, Nystrom L. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization. J Natl Cancer Inst Monogr. 1997;(22):57-61.

  20. Parkin DM, Whelan S, Ferlay J, eds. Cancer Incidence in Five Continents, Vol. VII IARC Scientific Publications N.143. Lyon: I.A.R.C; 1997.

  21. Greenspan FS, Strewler GJ, eds. Basic & Clinical Endocrinology. Upper Stadle River, New Jersey: Prentice Hall; 1997.

  22. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997; 26 Suppl 1: S6-14.

  23. Muti P, Trevisan M, Micheli A, Krogh V, Bolelli G, Sciajno R, Berrino F. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev. 1996 Nov; 5(11): 917-22.

  24. Chattoraj ST, Watts NB. Epidemiology. In: Tietz NW, editor. Fundamentals of clinical chemistry. Philadelphia (PA): Sounders Company, 1996: 553-613.

  25. La Vecchia C, Decarli A. Esophageal carcinoma. Ann Ist Super Sanità 1996;32(4):551-6.

  26. Buiatti E, Cipriani F. Etiological epidemiology of gastric tumors. Ann Ist Super Sanità 1996;32(4):557-71.

  27. Cipriani F, Geddes M. Etiological epidemiology of colorectal tumors. Ann Ist Super Sanità 1996;32(4):573-93.

  28. Rodella S, Picoco C. Epidemiology of malignant liver tumors. Ann Ist Super Sanità 1996;32(4):595-610.

  29. La Vecchia C. Pancreas carcinoma. Ann Ist Super Sanità 1996;32(4):611-4.

  30. Pirastu R, Iavarone I, Comba P. Bladder cancer: a selected review of the epidemiological literature. Ann Ist Super Sanità 1996;32(1):3-20.

  31. Corona R. Epidemiology of nonmelanoma skin cancer: a review. Ann Ist Super Sanità 1996;32(1):37-42.

  32. Russo A, Franceschi S. The epidemiology of esophageal cancer. Ann Ist Super Sanità 1996;32(1):65-72.

  33. Palli D. Epidemiology of gastric cancer. Ann Ist Super Sanità 1996;32(1):85-99.

  34. Buiatti E, Geddes M, Arniani S. Epidemiology of lung cancer. Ann Ist Super Sanità 1996;32(1):133-44.

  35. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996 Mar 6; 88(5): 291-6.

  36. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, Pisani P, Berrino F. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug; 4(5): 509-13.

  37. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15; 332(24): 1589-93.

  38. Zumoff B. Hormonal profiles in women with breast cancer. Obstet Gynecol Clin North Am. 1994 Dec;21(4):751-72. Review.

  39. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994; 18(2): 79-85.

  40. Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. Anticancer Res. 1994 Sep-Oct; 14(5B): 2113-7. Review.

  41. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol. 1994 Sep 15; 140(6): 518-25.

  42. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention.Cancer Epidemiol Biomarkers Prev. 1994 Jun; 3(4): 353-64.

  43. Wald N, Chamberlain J, Hackshaw A. Report of the European Society of Mastology Breast Cancer Screening Evaluation Committee. Tumori. 1993 Dec 31;79(6):371-9. Review. No abstract available. Erratum in: Tumori 1994 Aug 31;80(4):following 314.

  44. Cavalieri R, Macchini V, Mostaccioli S, Sonego G, Ferranti G, Corona R, Fucci M, Marzolini F, Rosmini F, Pasquini P. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991. Ann Ist Super Sanità 1993;29(3):469-72.

  45. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993 Apr 17;341(8851):973-8. Erratum in: Lancet 1993 Nov 27;342(8883):1372.

  46. Berrino F, Crosignani P. Epidemiology of malignant tumors of the larynx and lung. Ann Ist Super Sanità 1992;28(1):107-20.

  47. Comba P, Belli S. Etiological epidemiology of tumors of the nasal cavities and the paranasal sinuses. Ann Ist Super Sanità 1992;28(1):121-32.

  48. Merler E, Chellini E. Epidemiology of primary tumors of the pleura. Ann Ist Super Sanità 1992;28(1):133-46.

  49. Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res. 1991 May 15;51(10):2572-6.

  50. Vetrugno T, Comba P, Savelli D, Belli S, Magnani C. Epidemiologic surveillance of pleural mesothelioma in Italy. Ann Ist Super Sanita 1991;27(2):319-24.

  51. Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence District Programme.
    Int J Cancer. 1990 Aug 15;46(2):198-202.

  52. Peeters PH, Verbeek AL, Hendriks JH, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer. 1989 Jun;59(6):929-32.

  53. Secreto G, Toniolo P, Pisani P, Recchione C, Cavalleri A, Fariselli G, Totis A, Di Pietro S, Berrino F. Androgens and breast cancer in premenopausal women. Cancer Res. 1989 Jan 15;49(2):471-6.

  54. Zumoff B. Hormonal profiles in women with breast cancer (review). Anticancer Res. 1988 Jul-Aug; 8(4): 627-36. Review.

  55. Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29-43. Review.

  56. Berrino F, Pisani P, Muti P. Prospective study of hormones and diet in the aetiology of breast cancer. In: Riboli E, Saracci R. Diet hormones and cancer: methodological issues for prospective studies. IARC Technical Report N. 4. Lyon: I.A.R.C., 1988: 34-8.

  57. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol. 1987 May; 125(5): 791-9.

  58. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 1986 May; 15(2): 213-28. Review.

  59. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985 Sep 1; 56(5): 1206-8.

  60. Secreto G, Toniolo P, Berrino F, Recchione C, Di Pietro S, Fariselli G, Decarli A. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res. 1984 Dec; 44(12 Pt 1): 5902-5.

  61. Olsson H, Landin-Olsson M, Gullberg B. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. J Natl Cancer Inst. 1983 Jan; 70(1): 17-20.

  62. Grattarola R. Increased androgenic activity in well-differentiated endometrial adenocarcinoma. Gynecol Oncol. 1982 Aug; 14(1): 40-8. No abstract available.

  63. Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer. 1981 Aug; 44(2): 177-81.

  64. Henderson BE, Pike MC, Casagrande JT. Breast cancer and the oestrogen window hypothesis. Lancet. 1981 Aug 15; 2(8242): 363-4. No abstract available.

  65. Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions.Biometrics. 1978 Sep; 34(3): 483-6. No abstract available.

  66. Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab. 1974 Jul; 39(1): 145-9. No abstract available.

  67. Abraham GE.Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 1974 Aug; 39(2): 340-6. No abstract available.

  68. Grattarola R. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynecol. 1973 Jun 1; 116(3): 423-8.

  69. Bulbrook RD, Hayward JL, Spicer CC. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 1971 Aug 21;2(7721):395-8. No abstract available.

  70. Grattarola R. The premenstrual endometrial pattern of women with breast cancer: a study of progestational activity. Cancer. 1964 Sep; 17: 1119-22. No abstract available.

  71. Sommers SC, Theloh H.A. Ovarian stromal hyperplasia in breast cancer. Arch Pathol 1952; 53:160-167.

Non ci sono prodotti in questa categoria.